Note sull'episodio
In this Curie episode, Matt previews what’s coming at AACR 2025, happening April 25–30 in Chicago. Get ready for a data-packed week with practice-changing trials like KEYNOTE-689 and Beamion LUNG-1, along with fresh momentum in AI-powered oncology, cancer interception, and new modalities like peptide drug conjugates and RNA-targeting agents. From early detection to trial equity, this preview outlines the trends and themes every oncologist should be watching ahead of the meeting.
Parole chiave
HER2Head cancerNeck cancerNSCLCImmunotherapyAACRClinical trialsEarly cancer detectionCancer interceptionPredictive oncologyKRAS inhibitorsHER2 mutationsPARP inhibitorsCancer research